NCT02726828View on ClinicalTrials.gov

intrathecaم Ketamine, Morphine and Both for Lower Abdominal Cancer Surgery Pain

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

April 30, 2016

Conditions
Postoperative Pain
Interventions
DRUG

intrathecal morphine

patients received 10 mg of hyperbaric bupivacaine 0.5% in 2 ml volume and 0.3 mg intrathecal morphine1 ml volume.

DRUG

intrathecal ketamine

patients received 10 mg of hyperbaric bupivacaine 0.5% in 2 ml volume and 0.1 mg/kg intrathecal ketamine in 1ml volume.

DRUG

intrathecal morphine + ketamine

patients received 10 mg of hyperbaric bupivacaine 0.5% in 2 ml volume and intrathecal morphine + ketamine 0.3 mg and 0.1 mg/kg respectively in 1 ml volume.

All Listed Sponsors
lead

Assiut University

OTHER

NCT02726828 - intrathecaم Ketamine, Morphine and Both for Lower Abdominal Cancer Surgery Pain | Biotech Hunter | Biotech Hunter